Related Experiment Video
Updated: May 9, 2026

06:39
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Evidence of systematic duplication by new percutaneous coronary intervention programs
Thomas W Concannon1, Jason Nelson, David M Kent
1The RAND Corporation, Boston, MA 02116, USA. tconcann@rand.org
Circulation. Cardiovascular Quality and Outcomes
|July 11, 2013
Summary
New percutaneous coronary intervention (PCI) programs in US hospitals did not improve patient access to timely reperfusion. These duplicative services represent a significant, questionable investment in cardiovascular care.
Area of Science:
- Health Services Research
- Cardiovascular Medicine
- Health Economics
Background:
- Evidence indicates that investments in percutaneous coronary intervention (PCI) programs have not enhanced timely reperfusion access for ST-segment elevation myocardial infarction patients.
- Recent and projected investments in PCI may not align with improving patient outcomes.
Purpose of the Study:
- To estimate the number and cost of new PCI programs established in US hospitals between 2004 and 2008.
- To identify characteristics of hospitals, neighborhoods, and states associated with new PCI program introductions.
Main Methods:
- A discrete-time hazard model was employed to analyze factors influencing the decision to establish new PCI programs.
- Data from 2004 to 2008 were used to assess changes in PCI program availability and population access.
Main Results:
- The number of US hospitals performing PCI increased by 16.5% (251 hospitals) from 2004 to 2008.
- Population access to timely PCI grew by only 1.8% during the study period.
- New PCI programs were more prevalent in areas with existing programs, higher insurance rates, weaker regulation, and wealthier hospitals.
Conclusions:
- New PCI programs were found to be systematically duplicative of existing services.
- These new programs did not improve patient access to timely percutaneous coronary intervention.
- The substantial cost of new PCI programs raises concerns about their value for patient care.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
